Basit öğe kaydını göster

Treatment options in colchicine resistant familial Mediterranean fever patients: Thalidomide and etanercept as adjunctive agents

dc.contributor.authorOzdogan, H.
dc.contributor.authorYazici, H.
dc.contributor.authorCelik, S.
dc.contributor.authorUgurlu, S.
dc.contributor.authorSeyahi, E.
dc.date.accessioned2021-03-03T18:28:55Z
dc.date.available2021-03-03T18:28:55Z
dc.date.issued2006
dc.identifier.citationSeyahi E., Ozdogan H., Celik S., Ugurlu S., Yazici H., "Treatment options in colchicine resistant familial Mediterranean fever patients: Thalidomide and etanercept as adjunctive agents", CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, cilt.24, sa.5, 2006
dc.identifier.issn0392-856X
dc.identifier.othervv_1032021
dc.identifier.otherav_4f4acaef-b8c8-4c79-b01a-878da0b3fac2
dc.identifier.urihttp://hdl.handle.net/20.500.12627/56557
dc.description.abstractObjective. Regular colchicine treatment cannot control the typical febrile attacks of FMF in about 5-10% of the compliant patients. Here we report the effect of thalidomide and etanercept in 5 colchicine-resistant cases.
dc.language.isoeng
dc.subjectİmmünoloji ve Romatoloji
dc.subjectDahili Tıp Bilimleri
dc.subjectİç Hastalıkları
dc.subjectSağlık Bilimleri
dc.subjectTıp
dc.subjectKlinik Tıp (MED)
dc.subjectKlinik Tıp
dc.subjectROMATOLOJİ
dc.titleTreatment options in colchicine resistant familial Mediterranean fever patients: Thalidomide and etanercept as adjunctive agents
dc.typeMakale
dc.relation.journalCLINICAL AND EXPERIMENTAL RHEUMATOLOGY
dc.contributor.department, ,
dc.identifier.volume24
dc.identifier.issue5
dc.contributor.firstauthorID179817


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster